Diabetes
Article
A plan sponsor’s guide to GLP-1 medications for weight loss
July 10, 2023
GLP-1 medications are FDA-approved specifically for weight loss for more than half the adult population of the United States. Plan sponsors can take action to manage weight and other cardiodiabesity-r...
Article
Three of the biggest drivers of health care costs
Obesity, diabetes, and cardiovascular disease are on the rise. Left unmanaged, these comorbid conditions can cause medical expenses to skyrocket and lead to poor health outcomes, inclusive of disabili...
Read MoreArticle
Continuous glucose monitors and why you need them
September 06, 2022
Making Continuous Glucose Monitors available to members can improve health outcomes and decrease the total cost of care.
Article
Close management of diabetes medications lowers medical costs
June 16, 2022
Affordable diabetes treatment is critical for improving health outcomes, especially for the financially vulnerable.
Article
Underserved Communities at Greater Risk for Non-adherence to Diabetes Medication
May 12, 2022
Evernorth Geographic Social Determinants Index (EGSDI) identifies opportunities for proactive patient and community engagement for individuals diagnosed with type 2 diabetes.
Article
Affordability, Cost Predictability Can Help Patients With Diabetes and Cardiovascular Disease Thrive
August 25, 2021
Budget-friendly copays encourage adherence, especially with expensive disease states.